D’Alessandro, R., Refolo, M. G., Iacovazzi, P. A., Pesole, P. L., Messa, C., & Carr, B. I. (2019). Ramucirumab and GSK1838705A Enhance the Inhibitory Effects of Low Concentration Sorafenib and Regorafenib Combination on HCC Cell Growth and Motility. Cancers (Basel).

D’Alessandro, Rosalba, Maria Grazia Refolo, Palma Aurelia Iacovazzi, Pasqua Letizia Pesole, Caterina Messa, i Brian Irving Carr. "Ramucirumab and GSK1838705A Enhance the Inhibitory Effects of Low Concentration Sorafenib and Regorafenib Combination On HCC Cell Growth and Motility." Cancers (Basel) 2019.

D’Alessandro, Rosalba, et al. "Ramucirumab and GSK1838705A Enhance the Inhibitory Effects of Low Concentration Sorafenib and Regorafenib Combination On HCC Cell Growth and Motility." Cancers (Basel) 2019.